KDR and neoplasm: It not only directly inhibits tumor cell proliferation by blocking the cell signaling pathway mediated by Raf/MEK/ERK but also indirectly inhibits tumor cell growth by blocking tumor angiogenesis by inhibiting vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) 25.